Introduction to B2-Microglobulin Test Understanding B2-Microglobulin: A Biomarker Clinical Significance of B2-Microglobulin Indications and Applications of B2-Microglobulin Test Methodology: How B2-Microglobulin is Assessed Interpreting B2-Microglobulin Results B2-Microglobulin Test: Accuracy and Reliability Clinical Cases and B2-Microglobulin Future Directions in B2-Microglobulin Research Conclusion: Implications for Patient Care
he β2-Microglobulin test measures the levels of a protein called beta-2 microglobulin in the blood or urine. This test is often used to evaluate kidney function and to diagnose or monitor conditions such as kidney disease, certain cancers (particularly multiple myeloma and lymphoma), and autoimmune disorders. The β2-Microglobulin test measures the concentration of a protein called beta-2 microglobulin in the blood or urine. This test is commonly used to assess kidney function and to diagnose or monitor conditions like kidney disease, certain types of cancer (especially multiple myeloma and lymphoma), and autoimmune disorders.
Covid Safety
Assured
Free Report
Counselling
Recommended for You
How our test process works!
Beta-2 microglobulin (B2M) is a protein found on the surface of most nucleated cells and released into the blood, urine, or cerebrospinal fluid (CSF) during cell turnover. It is often measured to assess kidney function, immune system activity, and as a tumor marker in specific cancers.
Risk Assessment
-
Indications for Testing:
- Chronic Kidney Disease (CKD): To monitor kidney filtration and tubular function.
- Multiple Myeloma or Lymphoma: For disease prognosis or monitoring treatment effectiveness.
- Infections or Immune Disorders: To detect increased immune activity.
-
Associated Conditions:
- Increased Levels: Chronic kidney disease, multiple myeloma, lymphoma, HIV/AIDS, inflammatory conditions.
- Decreased Levels: Rarely clinically significant; usually indicates efficient kidney function.
Normal Range
- Serum or Plasma:
- Adults: 0.7–1.8 mg/L (may vary slightly by laboratory).
- Urine:
- < 0.3 mg/L is considered normal.
- CSF:
- Generally < 2.0 mg/L, but levels depend on age and condition.
Interpretation of Results
-
Increased Levels:
- Kidney Dysfunction: Poor filtration leads to accumulation in the blood.
- Active Cancer: Associated with multiple myeloma, lymphoma, or leukemia.
- Chronic Inflammatory Diseases: Elevated in autoimmune or chronic inflammatory conditions.
- Viral Infections: Seen in HIV or other viral infections that increase cell turnover.
-
Decreased Levels:
- Rarely significant; typically indicates normal kidney and immune function.
Sample Type
- Blood: Serum or plasma from a venipuncture.
- Urine: 24-hour urine sample or random spot sample.
- CSF: Collected via lumbar puncture if neurological involvement is suspected.
Frequently Asked Question
B2 - Microglobulin
Introduction to B2-Microglobulin Test Understanding B2-Microglobulin: A Biomarker Clinical Significance of B2-Microglobulin Indications and Applications of B2-Microglobulin Test Methodology: How B2-Microglobulin is Assessed Interpreting B2-Microglobulin Results B2-Microglobulin Test: Accuracy and Reliability Clinical Cases and B2-Microglobulin Future Directions in B2-Microglobulin Research Conclusion: Implications for Patient Care
he β2-Microglobulin test measures the levels of a protein called beta-2 microglobulin in the blood or urine. This test is often used to evaluate kidney function and to diagnose or monitor conditions such as kidney disease, certain cancers (particularly multiple myeloma and lymphoma), and autoimmune disorders. The β2-Microglobulin test measures the concentration of a protein called beta-2 microglobulin in the blood or urine. This test is commonly used to assess kidney function and to diagnose or monitor conditions like kidney disease, certain types of cancer (especially multiple myeloma and lymphoma), and autoimmune disorders.
Covid Safety
Assured
Free Report
Counselling